Blackstone Inc’s Pfizer PFE Stock Holding History

Blackstone Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-748,856	Closed	-$25M	–	121
2016 Q2	$25M	Buy	+748,856	New	+$23.9M	0.12%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Blackstone Inc's PFE Position: Q3 2016 in Review

Blackstone Inc sold out of Pfizer (PFE) in Q3 2016, closing a stake of 748,856 shares — an estimated $25M sold.

Blackstone Inc first reported a position in PFE in Q2 2016 and held it in 1 quarter. The position peaked at $25M in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Blackstone Inc reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Blackstone Inc sold 748,856 Pfizer shares in Q3 2016, an estimated $25M.
Blackstone Inc first reported a position in Pfizer in Q2 2016 and held it in 1 quarter.
Blackstone Inc's Pfizer position peaked at $25M in Q2 2016.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Blackstone Inc's 13F filing for Q3 2016, filed 14 Nov 2016.